| |
Before
|
After
|
Difference
|
p value
|
|---|
|
VQLQ
|
|
VQLQ-1
|
5.58 ± 1.51 [6 (1–7)]
|
3.05 ± 1.68 [3 (1–7)]
|
2.53 ± 1.59
|
<0.001
|
|
VQLQ-2
|
5.11 ± 1.66 [6 (2–7)]
|
2.61 ± 1.59 [3 (1–7)]
|
2.5 ± 1.73
|
<0.001
|
|
VQLQ-3
|
5.86 ± 1.41 [6 (2–7)]
|
3.52 ± 1.61 [3 (1–7)]
|
2.33 ± 1.62
|
<0.001
|
|
VQLQ-4
|
5.08 ± 1.82 [6 (1–7)]
|
2.72 ± 1.52 [3 (1–7)]
|
2.36 ± 1.74
|
<0.001
|
|
VQLQ-5
|
5.14 ± 1.79 [6 (2–7)]
|
2.97 ± 1.66 [3 (1–7)]
|
2.17 ± 1.95
|
<0.001
|
|
VQLQ-6
|
4.94 ± 2.12 [6 (1–7)]
|
2.88 ± 1.51 [3 (1–7)]
|
2.06 ± 1.80
|
<0.001
|
|
VQLQ-7
|
4.65 ± 2.08 [5 (1–7)]
|
2.22 ± 1.37 [2 (1–7)]
|
2.43 ± 1.93
|
<0.001
|
|
VQLQ-8
|
5.37 ± 1.66 [6 (1–7)]
|
2.74 ± 1.31 [3 (1–5)]
|
2.63 ± 1.77
|
<0.001
|
|
VQLQ-9
|
5.63 ± 1.23 [6 (3–7)]
|
2.86 ± 1.49 [3 (1–7)]
|
2.77 ± 1.68
|
<0.001
|
|
VQLQ-10
|
5.18 ± 1.65 [6 (1–7)]
|
2.77 ± 1.47 [3 (1–7)]
|
2.41 ± 1.68
|
<0.001
|
|
VQLQ-11
|
5.22 ± 1.62 [5 (1–7)]
|
2.56 ± 1.08 [3 (1–5)]
|
2.65 ± 1.58
|
<0.001
|
|
VQLQ-12
|
5.55 ± 1.63 [6 (2–7)]
|
2.95 ± 1.50 [2.5 (1–6)]
|
2.6 ± 1.47
|
<0.001
|
|
VQLQ-13
|
5.09 ± 1.59 [6 (2–7)]
|
2.75 ± 1.34 [3 (1–6)]
|
2.34 ± 1.56
|
<0.001
|
|
VQLQ-14
|
5.74 ± 1.37 [6 (2–7)]
|
2.80 ± 1.32 [3 (1–6)]
|
2.94 ± 1.55
|
<0.001
|
|
EoO
|
|
EoO-1
|
5.83 ± 1.18 [6 (2–7)]
|
2.58 ± 1.31 [2 (1–7)]
|
3.25 ± 1.78
|
<0.001
|
|
EoO-2
|
5.97 ± 1.14 [6 (3–7)]
|
2.73 ± 1.42 [3 (1–7)]
|
3.24 ± 1.94
|
<0.001
|
- VQLQ 1–14 (Vespid allergy quality of life questionnaire), EoO Expectation of Outcome questionnaire (questions 1 and 2) (independent measure)
